Sometimes, it’s best to leave work at the office

Article

Recent Videos
EyeCon 2024: Laura M. Periman, MD, shares her passion for dry eye disease, discussing her surprising discovery of the Alpenglow Sign in Demodex blepharitis
David Eichenbaum, MD, presents advances in AMD therapy, highlights different mechanisms with a common goal
Related Content
Alkeus Pharmaceuticals announces results from the SAGA study of oral gildeuretinol in patients with GA

Alkeus Pharmaceuticals announces results from the SAGA study of oral gildeuretinol in patients with GA

Article
Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics

Latest advances in X-linked retinitis pigmentosa: Optimizing diagnosis and developments in gene therapy

Podcast
4DMT presents data from phase 1/2 PRISM clinical trial and outlines 4FRONT phase 3 study

4DMT presents data from phase 1/2 PRISM clinical trial and outlines 4FRONT phase 3 study

Article
Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics

Advancing the optimal diagnosis & treatment of thyroid eye disease

Podcast
Ripple Therapeutics and AbbVie collaborate in development of RTC-620 for IOP reduction in patients with open-angle glaucoma

Ripple Therapeutics and AbbVie collaborate in development of RTC-620 for IOP reduction in patients with open-angle glaucoma

Article
Transforming the eye with a new standard for corneal cross-linking

Transforming the eye with a new standard for corneal cross-linking

Article
© 2024 MJH Life Sciences

All rights reserved.